U.S. pharma large copyright scrapped two experimental weight loss pills last yr—a after-each day tablet, lotiglipron, on account of elevated liver enzymes and a 2 times-day by day tablet, danuglipron, as a result of potent side effects—but CEO Albert Bourla has stated the company is determined to “Participate in and gain” within the obesity